The increased risk of nausea and vomiting will probably not come as a surprise to anyone who has taken these medications
LSM 8kPa were seen in 46 low-risk pts (83.6%), 24 intermediate-risk pts (64.9%), and all 4 high-risk pts (100%), while CAP 250 dB/m was detected in all pts with suspected MASLD
If your body has been in fight-or-flight for months or years, no medication can fully out-run that, because appetite suppression doesn't undo the stress response driving the fat storage in the first place
Avgerinos, K
In many cases you will find the name associated with scams
Side effects included nausea (39% of patients), diarrhea (25%) and vomiting (28%) [29] Overall, orfoglipron achieves comparable weight loss with other GLP1R agonists such as semaglutide and Rybelsus, but has a slightly better side effect profile and achieves weight loss in a shorter period of time